Differences and overlap in plasma protein expression during colorectal cancer progression

Show simple item record

dc.contributor University of Helsinki, Department of Surgery en
dc.contributor University of Helsinki, HUSLAB en
dc.contributor University of Helsinki, HUSLAB en
dc.contributor University of Helsinki, HUSLAB en
dc.contributor University of Helsinki, HUSLAB en
dc.contributor University of Helsinki, HUSLAB en
dc.contributor University of Helsinki, HUS Abdominal Center en
dc.contributor.author Holm, Matilda
dc.contributor.author Joenväärä, Sakari
dc.contributor.author Saraswat, Mayank
dc.contributor.author Tohmola, Tiialotta
dc.contributor.author Ristimäki, Ari
dc.contributor.author Renkonen, Risto
dc.contributor.author Haglund, Caj
dc.date.accessioned 2019-12-02T09:26:01Z
dc.date.available 2019-12-02T09:26:01Z
dc.date.issued 2019-08-05
dc.identifier.citation Holm , M , Joenväärä , S , Saraswat , M , Tohmola , T , Ristimäki , A , Renkonen , R & Haglund , C 2019 , ' Differences and overlap in plasma protein expression during colorectal cancer progression ' , Translational Medicine Communications , vol. 4 , no. 1 , 14 . https://doi.org/10.1186/s41231-019-0044-5 en
dc.identifier.issn 2396-832X
dc.identifier.other PURE: 126228201
dc.identifier.other PURE UUID: a65f58ee-4216-4345-8bb5-e69c9f6436d4
dc.identifier.other RIS: urn:084CA12B5618B020E2DFE49D43C0342E
dc.identifier.other RIS: Holm2019
dc.identifier.other ORCID: /0000-0001-8453-3936/work/76333954
dc.identifier.uri http://hdl.handle.net/10138/307751
dc.description.abstract Colorectal cancer (CRC) is the third most common cancer worldwide, and its incidence is expected to increase to over 2.2 million new cases in 2030. Stage II CRC is classified as localized disease, while stage III CRC has spread to regional lymph nodes. The 5-year survival rate is over 80% for patients with stage II CRC, but less than 60% for patients with stage III CRC. Proteins, especially plasma proteins that are detectable in easily obtained blood samples, that differ between stage II and III CRC could be useful for predicting and monitoring disease progression. CRC displays differences depending on primary tumor location (right colon, left colon, or rectum), and how plasma protein expression changes during CRC progression from stage II to III depending on primary tumor location is not well-characterized. en
dc.format.extent 12
dc.language.iso eng
dc.relation.ispartof Translational Medicine Communications
dc.rights en
dc.subject 3111 Biomedicine en
dc.title Differences and overlap in plasma protein expression during colorectal cancer progression en
dc.type Article
dc.description.version Peer reviewed
dc.identifier.doi https://doi.org/10.1186/s41231-019-0044-5
dc.type.uri info:eu-repo/semantics/other
dc.type.uri info:eu-repo/semantics/publishedVersion
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl
dc.contributor.pbl

Files in this item

Total number of downloads: Loading...

Files Size Format View
Holm2019_Articl ... cesAndOverlapInPlasmaP.pdf 927.5Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record